SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017854
Filing Date
2017-08-21
Accepted
2017-08-21 06:04:48
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-10q_20170630.htm 10-Q 1419581
2 EX-31.1 albo-ex311_9.htm EX-31.1 8313
3 EX-31.2 albo-ex312_7.htm EX-31.2 8191
4 EX-32.1 albo-ex321_8.htm EX-32.1 8649
  Complete submission text file 0001564590-17-017854.txt   5006230

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT albo-20170630.xml EX-101.INS 996749
6 XBRL TAXONOMY EXTENSION SCHEMA albo-20170630.xsd EX-101.SCH 36108
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE albo-20170630_cal.xml EX-101.CAL 34558
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE albo-20170630_def.xml EX-101.DEF 145836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20170630_lab.xml EX-101.LAB 322925
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20170630_pre.xml EX-101.PRE 242300
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 171042089
SIC: 2834 Pharmaceutical Preparations